Latest Insider Transactions at Paratek Pharmaceuticals, Inc. (PRTK)
This section provides a real-time view of insider transactions for Paratek Pharmaceuticals, Inc. (PRTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Paratek Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Paratek Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2023
|
Minnie Baylor Henry Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
59,200
-77.7%
|
-
|
|
Sep 21
2023
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
447,024
-90.02%
|
-
|
|
Sep 21
2023
|
Jeffrey Stein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
68,625
-85.43%
|
-
|
|
Sep 21
2023
|
Kristine Peterson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
79,000
-87.34%
|
-
|
|
Sep 21
2023
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Sale (or disposition) back to the issuer
|
Direct |
415,209
-89.7%
|
-
|
|
Sep 21
2023
|
Rolf K Hoffmann Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
84,000
-88.1%
|
-
|
|
Sep 21
2023
|
Evan Loh CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,327,981
-90.26%
|
-
|
|
Sep 21
2023
|
Adam Woodrow President & Chief Commercial |
SELL
Sale (or disposition) back to the issuer
|
Direct |
749,034
-91.54%
|
-
|
|
Sep 21
2023
|
Timothy R Franson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
72,000
-86.11%
|
-
|
|
Sep 21
2023
|
Michael Bigham Exec. Chairman of the Board |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,358,032
-91.58%
|
-
|
|
Sep 21
2023
|
Robert S Radie Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
73,000
-86.3%
|
-
|
|
Sep 21
2023
|
Thomas John Dietz Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
69,250
-85.56%
|
-
|
|
Aug 09
2023
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
31,250
-2.29%
|
$62,500
$2.2 P/Share
|
|
Aug 09
2023
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
27,603
-6.23%
|
$55,206
$2.2 P/Share
|
|
Aug 09
2023
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
34,526
-7.17%
|
$69,052
$2.2 P/Share
|
|
Aug 09
2023
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
48,967
-3.56%
|
$97,934
$2.2 P/Share
|
|
Aug 08
2023
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
98,750
+11.63%
|
-
|
|
Aug 08
2023
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
156,250
+10.26%
|
-
|
|
Aug 08
2023
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
67,500
+13.23%
|
-
|
|
Aug 08
2023
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
73,750
+13.28%
|
-
|
|
Aug 08
2023
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
168,750
+10.92%
|
-
|
|
Mar 23
2023
|
James D Dondero > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+4.43%
|
$100,000
$1.73 P/Share
|
|
Mar 22
2023
|
James D Dondero > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
106,000
+4.9%
|
$106,000
$1.77 P/Share
|
|
Mar 21
2023
|
James D Dondero > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
242,500
+15.64%
|
$242,500
$1.74 P/Share
|
|
Mar 20
2023
|
James D Dondero > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
105,137
+4.48%
|
$105,137
$1.4 P/Share
|
|
Mar 17
2023
|
James D Dondero > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
234,863
+9.91%
|
$234,863
$1.5 P/Share
|
|
Feb 21
2023
|
Jeffrey Stein Director |
SELL
Open market or private sale
|
Direct |
7,000
-9.26%
|
$7,000
$1.9 P/Share
|
|
Feb 21
2023
|
Timothy R Franson Director |
SELL
Open market or private sale
|
Direct |
7,000
-8.86%
|
$7,000
$1.88 P/Share
|
|
Feb 08
2023
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+21.68%
|
-
|
|
Feb 08
2023
|
Jeffrey Stein Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+20.92%
|
-
|
|
Feb 08
2023
|
Kristine Peterson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+20.2%
|
-
|
|
Feb 08
2023
|
Rolf K Hoffmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+19.23%
|
-
|
|
Feb 08
2023
|
Timothy R Franson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+20.2%
|
-
|
|
Feb 08
2023
|
Thomas John Dietz Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+22.22%
|
-
|
|
Feb 08
2023
|
Minnie Baylor Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+25.25%
|
-
|
|
Dec 21
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
4,539
-1.34%
|
$4,539
$1.99 P/Share
|
|
Dec 21
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
7,007
-1.69%
|
$7,007
$1.99 P/Share
|
|
Dec 21
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
23,489
-1.91%
|
$23,489
$1.99 P/Share
|
|
Dec 21
2022
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
6,750
-1.03%
|
$6,750
$1.99 P/Share
|
|
Dec 21
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
15,750
-1.29%
|
$15,750
$1.99 P/Share
|
|
Dec 20
2022
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+4.23%
|
-
|
|
Dec 20
2022
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+3.49%
|
-
|
|
Dec 20
2022
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
52,500
+4.09%
|
-
|
|
Dec 20
2022
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+3.31%
|
-
|
|
Dec 20
2022
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+3.54%
|
-
|
|
Dec 13
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
31,891
-2.63%
|
$31,891
$1.96 P/Share
|
|
Dec 13
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
18,177
-5.3%
|
$18,177
$1.96 P/Share
|
|
Dec 13
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
23,584
-5.57%
|
$23,584
$1.96 P/Share
|
|
Dec 13
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
61,919
-4.99%
|
$61,919
$1.96 P/Share
|
|
Dec 13
2022
|
Adam Woodrow President & Chief Commercial |
SELL
Open market or private sale
|
Direct |
6,253
-0.97%
|
$6,253
$1.96 P/Share
|